These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24424017)

  • 1. Late survival after aortic valve replacement with the perimount versus the mosaic bioprosthesis.
    Glaser N; Franco-Cereceda A; Sartipy U
    Ann Thorac Surg; 2014 Apr; 97(4):1314-20. PubMed ID: 24424017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
    Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis.
    Dellgren G; David TE; Raanani E; Armstrong S; Ivanov J; Rakowski H
    J Thorac Cardiovasc Surg; 2002 Jul; 124(1):146-54. PubMed ID: 12091820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 50-65 years.
    Bourguignon T; Lhommet P; El Khoury R; Candolfi P; Loardi C; Mirza A; Boulanger-Lothion J; Bouquiaux-Stablo-Duncan AL; Marchand M; Aupart M
    Eur J Cardiothorac Surg; 2016 May; 49(5):1462-8. PubMed ID: 26530269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of early redo surgery rates in Mosaic porcine and Perimount bovine pericardial valves.
    Webb J; Parkin D; Tøndel K; Simitsis P; Roxburgh J; Chambers JB
    Eur J Cardiothorac Surg; 2018 Oct; 54(4):724-728. PubMed ID: 29579171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position.
    Bourguignon T; Bouquiaux-Stablo AL; Candolfi P; Mirza A; Loardi C; May MA; El-Khoury R; Marchand M; Aupart M
    Ann Thorac Surg; 2015 Mar; 99(3):831-7. PubMed ID: 25583467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Clinical Outcomes of the Carpentier-Edwards Perimount Pericardial Bioprosthesis in Chinese Patients with Single or Multiple Valve Replacement in Aortic, Mitral, or Tricuspid Positions.
    Guo H; Lu C; Huang H; Xie B; Liu J; Zheng S; Fan R; Chen J; Zhuang J
    Cardiology; 2017; 138(2):97-106. PubMed ID: 28618423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of carpentier-edwards supraannular prosthesis versus mosaic aortic prosthesis: 6 year results.
    Birla R; Twine G; Unsworth-White J
    Ann Thorac Surg; 2013 Mar; 95(3):831-7. PubMed ID: 23201103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perimount valve in the aortic position: twenty-year experience with patients under 60 years old.
    Forcillo J; El Hamamsy I; Stevens LM; Badrudin D; Pellerin M; Perrault LP; Cartier R; Bouchard D; Carrier M; Demers P
    Ann Thorac Surg; 2014 May; 97(5):1526-32. PubMed ID: 24681031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of completely supra-annular placement of bioprostheses on exercise hemodynamics in patients with a small aortic annulus.
    Wagner IM; Eichinger WB; Bleiziffer S; Botzenhardt F; Gebauer I; Guenzinger R; Bauernschmitt R; Lange R
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1234-41. PubMed ID: 17467435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effective orifice area/patient aortic annulus area ratio: a better way to compare different bioprostheses? A prospective randomized comparison of the Mosaic and Perimount bioprostheses in the aortic position.
    Eichinger WB; Botzenhardt F; Guenzinger R; Bleiziffer S; Keithahn A; Bauernschmitt R; Lange R
    J Heart Valve Dis; 2004 May; 13(3):382-8; discussion 388-9. PubMed ID: 15222284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after Carpentier-Edwards Perimount aortic valve replacement in Western Denmark: a multi-centre observational study.
    Krasniqi L; Kronby MP; Riber LPS
    J Cardiothorac Surg; 2021 May; 16(1):130. PubMed ID: 33990211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation after sorin freedom solo valve implantation: a comparative study with Carpentier-Edwards Perimount Magna.
    Repossini A; Tononi L; Martinil G; Di Bacco L; Girolettiz L; Rosati F; Muneretto C
    J Heart Valve Dis; 2014 Nov; 23(6):777-82. PubMed ID: 25790627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new St Jude Trifecta versus Carpentier-Edwards Perimount Magna and Magna Ease aortic bioprosthesis: is there a hemodynamic superiority?
    Wendt D; Thielmann M; Plicht B; Aßmann J; Price V; Neuhäuser M; Jakob H
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1553-60. PubMed ID: 23870159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-year follow-up of aortic valve reoperation rates: Carpentier-Edwards Perimount versus St. Jude Medical Trifecta.
    Stubeda H; Aliter H; Gainer RA; Theriault C; Doucette S; Hirsch GM
    J Card Surg; 2020 Dec; 35(12):3347-3353. PubMed ID: 32985014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.
    McClure RS; Narayanasamy N; Wiegerinck E; Lipsitz S; Maloney A; Byrne JG; Aranki SF; Couper GS; Cohn LH
    Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrodynamic Performance of the Medtronic CoreValve and the Edwards SAPIEN XT Transcatheter Heart Valve in Surgical Bioprostheses: An In Vitro Valve-in-Valve Model.
    Sedaghat A; Sinning JM; Utzenrath M; Ghalati PF; Schmitz C; Werner N; Nickenig G; Grube E; Ensminger S; Steinseifer U; Kuetting M
    Ann Thorac Surg; 2016 Jan; 101(1):118-24. PubMed ID: 26363653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age.
    Weber A; Noureddine H; Englberger L; Dick F; Gahl B; Aymard T; Czerny M; Tevaearai H; Stalder M; Carrel TP
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1075-83. PubMed ID: 22341653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trifecta Versus Perimount Magna Ease Aortic Valve Prostheses.
    Biancari F; Valtola A; Juvonen T; Husso A; Dahlbacka S; Laakso T; Jalava MP; Tauriainen T; Ahvenvaara T; Kinnunen EM; Niemelä M; Mäkikallio T; Eskola M; Virtanen MPO; Maaranen P; Rosato S; Anttila V; Vento A; Airaksinen J; Raivio P
    Ann Thorac Surg; 2020 Sep; 110(3):879-888. PubMed ID: 32061588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcomes of Mosaic Versus Perimount Mitral Replacements: 17-Year Follow-Up of 940 Implants.
    Beute TJ; Goehler M; Parker J; Boeve T; Heiser J; Murphy E; Timek T; Willekes CL
    Ann Thorac Surg; 2020 Aug; 110(2):508-515. PubMed ID: 31866480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.